EFDID: 508668EFD: View Filing

Issuer: NexPoint Life Sciences III DST (0002008210) - D

Accession: 0002008210-24-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002008210
  • Entity Name:
    NexPoint Life Sciences III DST
  • Entity Type:
    Other
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2023)
  • Address:
    300 CRESCENT COURT
    SUITE 700
    DALLAS, TX 75201
  • Persons:
    Related Persons 5
    N/A NexPoint Real Estate Advisors IV, L.P.
    Executive Officer 
    Sponsor of the Issuer
    Brian Mitts
    Executive Officer 
    Authorized Signatory of the Issuer
    Matt McGraner
    Executive Officer 
    Authorized Signatory of the Issuer
    N/A NREA LS III Manager, LLC
    Executive Officer 
    Manager and Signatory Trustee of the Issuer
    N/A NREA LS III Contributor, LLC
    Executive Officer 
    Contributor of the Issuer
EDGAR: Offering Information
  • Accession Date:
    01/31/2024
  • First Sale Date:
    01/25/2024
  • Offering Amount:
    $30,661,253
  • Amount Sold:
    $148,529
  • Amount Remaining:
    $30,512,724
  • Exemptions:
    Section 3(c)(1) , Rule 506(c), Investment Company Act Section 3(c) , Section 3(c)(5)
  • Security Type(s):
    Equity, Pooled Investment Fund
  • Sales Clarification:
    Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AZ, CA, CO, HI, IL, KS, MA, MD, ME, MN, NC, NM, NV, OK, OR, PA, SC, TX, WA, WI
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Aurora Securities 46147 None None WA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
NexPoint Life Sciences III DST/s/Brian MittsBrian MittsAuthorized Signatory of the Issuer2024-01-31
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jan. 13, 2026 508668: 0002008210-26-000001 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $25,178,789
Remaining: $5,482,464
D/A Aug. 06, 2025 508668: 0002008210-25-000004 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $14,150,789
Remaining: $16,510,464
D/A Apr. 18, 2025 508668: 0002008210-25-000003 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $11,537,013
Remaining: $19,124,240
D/A Jan. 29, 2025 508668: 0002008210-25-000002 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $9,865,646
Remaining: $20,795,607
D/A Jan. 22, 2025 508668: 0002008210-25-000001 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $9,565,646
Remaining: $21,095,607
D/A Dec. 17, 2024 508668: 0002008210-24-000011 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $8,610,539
Remaining: $22,050,714
D/A Nov. 06, 2024 508668: 0002008210-24-000010 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $6,566,766
Remaining: $24,094,487
D/A Oct. 16, 2024 508668: 0002008210-24-000009 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $4,789,837
Remaining: $25,871,416
D/A Sep. 26, 2024 508668: 0002008210-24-000008 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $4,198,753
Remaining: $26,462,500
D/A Aug. 12, 2024 508668: 0002008210-24-000007 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $4,023,753
Remaining: $26,637,500
D/A Jul. 10, 2024 508668: 0002008210-24-000006 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $2,913,131
Remaining: $27,748,122
D/A May. 21, 2024 508668: 0002008210-24-000005 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $1,946,858
Remaining: $28,714,395
D/A Mar. 26, 2024 508668: 0002008210-24-000004 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $1,551,858
Remaining: $29,109,395
D/A Mar. 12, 2024 508668: 0002008210-24-000003 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $517,406
Remaining: $30,143,847
D/A Feb. 21, 2024 508668: 0002008210-24-000002 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $417,406
Remaining: $30,243,847
D Jan. 31, 2024 508668: 0002008210-24-000001 NexPoint Life Sciences III DST
Offer Amount: $30,661,253
Amount Sold: $148,529
Remaining: $30,512,724